Publication | Closed Access

Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy

NanomedicineNanotherapeuticsDrug-resistant Cancer TherapyPolymer-drug ConjugateMedicinePeptide TherapeuticDrug Delivery SystemsTumor TargetingCancer-specific Drug-drug NanoparticlesPharmacologyRadiation Oncology